ATE340188T1 - Transkriptionsfaktoren welche zwei potentielle dna bindende motive enthalten - Google Patents

Transkriptionsfaktoren welche zwei potentielle dna bindende motive enthalten

Info

Publication number
ATE340188T1
ATE340188T1 AT00977763T AT00977763T ATE340188T1 AT E340188 T1 ATE340188 T1 AT E340188T1 AT 00977763 T AT00977763 T AT 00977763T AT 00977763 T AT00977763 T AT 00977763T AT E340188 T1 ATE340188 T1 AT E340188T1
Authority
AT
Austria
Prior art keywords
contain
dna binding
transcription factors
potential dna
nucleic acid
Prior art date
Application number
AT00977763T
Other languages
English (en)
Inventor
Alison Banham
Jacqueline Loelia Cordell
Margaret Jones
Original Assignee
Isis Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9928543.9A external-priority patent/GB9928543D0/en
Priority claimed from GB0017042A external-priority patent/GB0017042D0/en
Application filed by Isis Innovation filed Critical Isis Innovation
Application granted granted Critical
Publication of ATE340188T1 publication Critical patent/ATE340188T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT00977763T 1999-12-02 2000-12-01 Transkriptionsfaktoren welche zwei potentielle dna bindende motive enthalten ATE340188T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9928543.9A GB9928543D0 (en) 1999-12-02 1999-12-02 Novel transcription factors
GB0017042A GB0017042D0 (en) 2000-07-11 2000-07-11 Novel transcription factors

Publications (1)

Publication Number Publication Date
ATE340188T1 true ATE340188T1 (de) 2006-10-15

Family

ID=26244636

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00977763T ATE340188T1 (de) 1999-12-02 2000-12-01 Transkriptionsfaktoren welche zwei potentielle dna bindende motive enthalten

Country Status (9)

Country Link
US (1) US20030139330A1 (de)
EP (1) EP1246841B1 (de)
JP (1) JP2003515328A (de)
AT (1) ATE340188T1 (de)
AU (1) AU1539801A (de)
CA (1) CA2394996A1 (de)
DE (1) DE60030884T2 (de)
ES (1) ES2272336T3 (de)
WO (1) WO2001040303A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003241832A1 (en) * 2002-05-28 2003-12-12 Japan Genome Solutions, Inc. Dna microarray data processing method, dna microarray data processing system, dna microarray data processor, program and recording medium
WO2005095447A2 (en) * 2004-03-29 2005-10-13 Isis Innovation Limited Low molecular weight forms of foxp1 proteins and splice variants thereof
ATE459720T1 (de) * 2004-08-18 2010-03-15 Bayer Cropscience Ag Pflanzen mit erhöhter plastidär aktivität der stärkephosphorylierenden r3-enzyme
CA2752947A1 (en) * 2011-06-30 2012-12-30 Benjamin J. Blencowe Foxp1 splice variants and methods and uses thereof
WO2013063019A1 (en) 2011-10-28 2013-05-02 The Wistar Institute Of Anatomy And Biology Methods and compositions for enhancing the therapeutic effect of anti-tumor t cells
US10842565B2 (en) 2016-02-22 2020-11-24 The General Hospital Corporation Systems and methods for selective targeting of structural features in treating skin conditions
US20230365637A1 (en) * 2020-09-28 2023-11-16 The Research Institute At Nationwide Children's Hospital Identification of pax3-foxo1 binding genomic regions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19820190A1 (de) * 1998-04-28 1999-11-04 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Pankreas-Tumor

Also Published As

Publication number Publication date
DE60030884T2 (de) 2007-04-26
DE60030884D1 (de) 2006-11-02
AU1539801A (en) 2001-06-12
WO2001040303A1 (en) 2001-06-07
CA2394996A1 (en) 2001-06-07
ES2272336T3 (es) 2007-05-01
JP2003515328A (ja) 2003-05-07
EP1246841A1 (de) 2002-10-09
US20030139330A1 (en) 2003-07-24
EP1246841B1 (de) 2006-09-20

Similar Documents

Publication Publication Date Title
DE69831224D1 (de) Immuntoxine, die ein onc protein enthalten, gegen bösartige zellen
NO961812D0 (no) Humanproteaseinhibitorer av Kunitz-type
DE69935248D1 (de) Dna-protein fusionen sowie anwendungen derselben
DE69942861D1 (de) Ldcam genannte moleküle
CA2181548A1 (en) Zinc finger protein derivatives and methods therefor
AU4567499A (en) Novel mtbx protein and nucleic acid molecules and uses therefor
ATE113077T1 (de) Stabile integration von dna in bakterielle genome.
DE69018117D1 (de) Zur Synthese von Karotinoiden verwendbare DNA-Sequenzen.
ATE350472T1 (de) Jmy, mit-aktivator für p300/cbp, dafür kodierendenucleinsäure und deren verwendungen
DE60030884D1 (de) Transkriptionsfaktoren welche zwei potentielle dna bindende motive enthalten
HUT77029A (hu) A GAP-protein SH3 doménjéhez kötődni képes peptidek, ezeket kódoló nukleotidszekvenciák és előállításuk és alkalmazásuk
ATE441712T1 (de) Die nukleotidsequenz ann bindende zink-finger domänen
DK0877758T3 (da) Oprenset SR-p70-protein
EP0785716A4 (de) Als lerk6 bezeichnetes cytokin
EP0809103A3 (de) Stabile Denaturierungsmittel für elektroforetische Techniken und dafür geeignete Verfahren
EA199900256A1 (ru) Нуклеотидная и белковая последовательность маммастатина и способы применения
Jones The terminology of guanidine formation
WO2004034093A3 (en) Caterpiller gene family
KR960010861A (ko) 사람 전사 인자 iiia 유전자
WO2003062447A3 (en) Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
ATE393224T1 (de) Nukleinsäuresequenzen von hyperplasien und tumoren der schilddrüse
ATE275207T1 (de) Dna zur abschätzung des progressionspotentials von zervixläsionen
BG103342A (en) Gax protein domains-containing polypeptides included in the presented transcription and/or interrelated to other proteins corresponding to neucleinic acids, and their application
WO1997026276A3 (en) Vertebrate fringe proteins
AU5312699A (en) Novel mp-7 protein and nucleic acid molecules and uses therefor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties